144 related articles for article (PubMed ID: 1465025)
1. Differential macrophage-mediated cytotoxicity to P388 leukemia cells and its drug-resistant cells examined by a new MTT assay.
Jiao H; Soejima Y; Ohe Y; Miura K; Tamura T; Saijo N
Leuk Res; 1992 Dec; 16(12):1175-80. PubMed ID: 1465025
[TBL] [Abstract][Full Text] [Related]
2. A new 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay for testing macrophage cytotoxicity to L1210 and its drug-resistant cell lines in vitro.
Jiao H; Shen W; Ohe Y; Miura K; Tamura T; Saijo N
Cancer Immunol Immunother; 1992; 35(6):412-6. PubMed ID: 1394344
[TBL] [Abstract][Full Text] [Related]
3. MTT colorimetric assay for testing macrophage cytotoxic activity in vitro.
Ferrari M; Fornasiero MC; Isetta AM
J Immunol Methods; 1990 Aug; 131(2):165-72. PubMed ID: 2391427
[TBL] [Abstract][Full Text] [Related]
4. Antineoplastic activity of mitoxantrone and its biological interactions in parental and multidrug resistant subline of P388 murine leukemia cells.
Chavan S; Parekh H; Chitnis M
Neoplasma; 1992; 39(1):49-57. PubMed ID: 1528304
[TBL] [Abstract][Full Text] [Related]
5. A new MTT assay for examining the cytotoxicity of activated macrophages towards the non-adherent P388 leukaemia cell line.
Jiao H; Soejima Y; Ohe Y; Saijo N
J Immunol Methods; 1992 Aug; 153(1-2):265-6. PubMed ID: 1517599
[No Abstract] [Full Text] [Related]
6. The MTT cell viability assay for cytotoxicity testing in multidrug-resistant human leukemic cells.
Marks DC; Belov L; Davey MW; Davey RA; Kidman AD
Leuk Res; 1992 Dec; 16(12):1165-73. PubMed ID: 1361210
[TBL] [Abstract][Full Text] [Related]
7. Chemosensitivity and radiosensitivity of small cell lung cancer cell lines studied by a newly developed 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) hybrid assay.
Hida T; Ueda R; Takahashi T; Watanabe H; Kato T; Suyama M; Sugiura T; Ariyoshi Y; Takahashi T
Cancer Res; 1989 Sep; 49(17):4785-90. PubMed ID: 2547517
[TBL] [Abstract][Full Text] [Related]
8. In vitro antitumor activity of mitomycin C derivative (RM-49) and new anticancer antibiotics (FK973) against lung cancer cell lines determined by tetrazolium dye (MTT) assay.
Horiuchi N; Nakagawa K; Sasaki Y; Minato K; Fujiwara Y; Nezu K; Ohe Y; Saijo N
Cancer Chemother Pharmacol; 1988; 22(3):246-50. PubMed ID: 2842080
[TBL] [Abstract][Full Text] [Related]
9. Cell mediated cytotoxicity against U 937 cells by human monocytes and macrophages in a modified colorimetric MTT assay. A methodological study.
van de Loosdrecht AA; Nennie E; Ossenkoppele GJ; Beelen RH; Langenhuijsen MM
J Immunol Methods; 1991 Jul; 141(1):15-22. PubMed ID: 1865120
[TBL] [Abstract][Full Text] [Related]
10. Potentiation of mitomycin C cytotoxicity by glutathione depletion in a multi-drug resistant mouse leukemia cell line.
Xu BH; Singh SV
Cancer Lett; 1992 Sep; 66(1):49-53. PubMed ID: 1451095
[TBL] [Abstract][Full Text] [Related]
11. Effects of the pH dependence of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide-formazan absorption on chemosensitivity determined by a novel tetrazolium-based assay.
Plumb JA; Milroy R; Kaye SB
Cancer Res; 1989 Aug; 49(16):4435-40. PubMed ID: 2743332
[TBL] [Abstract][Full Text] [Related]
12. Application of the MTT assay to human prostate cancer cell lines in vitro: establishment of test conditions and assessment of hormone-stimulated growth and drug-induced cytostatic and cytotoxic effects.
Romijn JC; Verkoelen CF; Schroeder FH
Prostate; 1988; 12(1):99-110. PubMed ID: 3126493
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of a rapid tetrazolium-based colorimetric assay for selecting anticancer drugs.
Chen CF; Hwang JM; Wu CH; Chen CS; Chen KY
Zhonghua Yi Xue Za Zhi (Taipei); 1990 Jul; 46(1):7-16. PubMed ID: 2176928
[TBL] [Abstract][Full Text] [Related]
14. An improved 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) reduction assay for evaluating the viability of Escherichia coli cells.
Wang H; Cheng H; Wang F; Wei D; Wang X
J Microbiol Methods; 2010 Sep; 82(3):330-3. PubMed ID: 20619304
[TBL] [Abstract][Full Text] [Related]
15. Rapid cytocidal and cytostatic chemosensitivity test by measuring total amount of mRNA.
Miura Y; deFries R; Shimada H; Mitsuhashi M
Cancer Lett; 1997 Jun; 116(2):139-44. PubMed ID: 9215856
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of tetrazolium-based semiautomatic colorimetric assay for measurement of human antitumor cytotoxicity.
Heo DS; Park JG; Hata K; Day R; Herberman RB; Whiteside TL
Cancer Res; 1990 Jun; 50(12):3681-90. PubMed ID: 2340518
[TBL] [Abstract][Full Text] [Related]
17. Cholesterol interferes with the MTT assay in human epithelial-like (A549) and endothelial (HLMVE and HCAE) cells.
Ahmad S; Ahmad A; Schneider KB; White CW
Int J Toxicol; 2006; 25(1):17-23. PubMed ID: 16510353
[TBL] [Abstract][Full Text] [Related]
18. Effects of cis-unsaturated fatty acids on doxorubicin sensitivity in P388/DOX resistant and P388 parental cell lines.
Liu QY; Tan BK
Life Sci; 2000; 67(10):1207-18. PubMed ID: 10954054
[TBL] [Abstract][Full Text] [Related]
19. Test for chemotherapeutic sensitivity of cerebral gliomas: use of colorimetric MTT assay.
Jordan JP; Hand CM; Markowitz RS; Black P
J Neurooncol; 1992 Sep; 14(1):19-35. PubMed ID: 1335043
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of P-glycoprotein and alterations in topoisomerase II in P388 mouse leukemia cells selected in vivo for resistance to mitoxantrone.
Kamath N; Grabowski D; Ford J; Kerrigan D; Pommier Y; Ganapathi R
Biochem Pharmacol; 1992 Sep; 44(5):937-45. PubMed ID: 1356339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
